Skip to main content
Log in

Loss of hMSH2 gene expression correlates with improved survival in patients with sporadic colorectal cancer

  • Research Note
  • Published:
Journal of Genetics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  • Ahmed F. E. 2003 Colon cancer: prevalence, screening, gene expression and mutation, and risk factors and assessment. J. Environ. Sci. Health C. Environ. Carcinog. Ecotoxicol. Rev. 21, 65–131.

    PubMed  Google Scholar 

  • Chen W. S., Chen J. Y., Liu J. M., Lin W. C., King K. L., Whang-Peng J. and Yang W. K. 1997 Microsatellite instability in sporadic-colon-cancer patients with and without liver metastases. Int. J. Cancer 74, 470–474.

    Article  CAS  PubMed  Google Scholar 

  • Christensen L. L., Madsen B. E., Wikman F. P., Wiuf C., Koed K., Tjnneland A. et al. 2008 The association between genetic variants in hMLH1 and hMSH2 and the development of sporadic colorectal cancer in the Danish population. BMC Med. Genet. 9, 52.

    Article  PubMed  Google Scholar 

  • Cunningham J.M., Christensen E. R., Tester D. J., Kim C.Y., Roche P. C., Burgart L. J. and Thibodeau S. N. 1998 Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability. Cancer Res. 58, 3455–3460.

    CAS  PubMed  Google Scholar 

  • Gryfe R., Kim H., Hsieh E. T., Aronson M. D., Holowaty E. J., Bull S. B. et al. 2000 Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. N. Engl. J. Med. 342, 69–77.

    Article  CAS  PubMed  Google Scholar 

  • Jansson A., Arbman G., Zhang H. and Sun X. F. 2003 Combined deficiency of hMLH1, hMSH2, hMSH3 and hMSH6 is an independent prognostic factor in colorectal cancer. Int. J. Oncol. 22, 41–49.

    CAS  PubMed  Google Scholar 

  • Peltomaki P. 2001 Deficient DNA mismatch repair: a common etiologic factor for colon cancer. Hum. Mol. Genet. 10, 735–740.

    Article  CAS  PubMed  Google Scholar 

  • Kamory E., Kolacsek O., Otto S. and Csuka O. 2003 hMLH1 and hMSH2 somatic inactivation mechanisms in sporadic colorectal cancer patients. Pathol. Oncol. Res. 9, 236–241.

    Article  CAS  PubMed  Google Scholar 

  • Kim H., Piao Z., Kim J.W., Choi J. S., Kim N.K., Lee J.M. N. and Park J. H. 1998 Expression of hMSH2 and hMLH1 in colorectal carcinomas with microsatellite instability. Pathol. Res. Pract. 194, 3–9.

    CAS  PubMed  Google Scholar 

  • Kim J. C., Roh S. A., Koo K. H., Ka I.H., Kim H.C., Yu C. S. et al. 2004 Genotyping possible polymorphic variants of human mismatch repair genes in healthy Korean individuals and sporadic colorectal cancer patients. Fam. Cancer 3, 129–137.

    Article  CAS  PubMed  Google Scholar 

  • Kruschewski M., Noske A., Haier J., Runkel N., Anagnostopoulos Y. and Buhr H. J. 2002 Is reduced expression of mismatch repair genes MLH1 and MSH2 in patients with sporadic colorectal cancer related to their prognosis? Clin. Exp. Metastasis 19, 71–77.

    Article  CAS  PubMed  Google Scholar 

  • Leach F. S., Hsieh J. T., Molberg K., Saboorian M. H., McConnell J. D. and Sagalowsky A. I. 2000 Expression of the human mismatch repair gene hMSH2: a potential marker for urothelial malignancy. Cancer 88, 2333–2341.

    Article  CAS  PubMed  Google Scholar 

  • Maeda K., Nishiguchi Y., Onoda N., Otani H., Nakata B., Yamada S. et al. 1998 Expression of the mismatch repair gene hMSH2 in sporadic colorectal cancer. Int. J. Oncol. 13, 1147–1151.

    CAS  PubMed  Google Scholar 

  • Perrin J., Gouvernet J., Parriaux D., Noguchi T., Giovannini M. H., Giovannini M. et al. 2001 MSH2 and MLH1 immunodetection and the prognosis of colon cancer. Int. J. Oncol. 19, 891–895.

    CAS  PubMed  Google Scholar 

  • Plevova P., Sedlakova E., Zapletalova J., Krepelova A., Skypalova P. and Kolar Z. 2005 Expression of the hMLH1 and hMSH2 proteins in normal tissues: relationship to cancer predisposition in hereditary non-polyposis colon cancer. Virchows Arch. 446, 112–119.

    Article  CAS  PubMed  Google Scholar 

  • Pors K. and Patterson L. H. 2005 DNA mismatch repair deficiency, resistance to cancer chemotherapy and the development of hypersensitive agents. Curr. Top Med. Chem. 5, 1133–1149.

    Article  CAS  PubMed  Google Scholar 

  • Thibodeau S. N., French A. J., Roche P. C., Cunningham J. M., Tester D. J., Lindor N. M. et al. 1996 Altered expression of hMSH2 and hMLH1 in tumors with microsatellite instability and genetic alterations in mismatch repair genes. Cancer Res. 56, 4836–4840.

    CAS  PubMed  Google Scholar 

  • Uehara H., Miyamoto M., Kato K., Cho Y., Kurokawa T., Murakami S. et al. 2005 Deficiency of hMLH1 and hMSH2 expression is a poor prognostic factor in esophageal squamous cell carcinoma. J. Surg. Oncol. 92, 109–115.

    Article  CAS  PubMed  Google Scholar 

  • Ward R., Meagher A., Tomlinson I., O’Connor T., Norrie M., Wu R. and Hawkins N. 2001 Microsatellite instability and the clinicopathological features of sporadic colorectal cancer. Gut 48, 821–829.

    Article  CAS  PubMed  Google Scholar 

  • Zhang H., Fu W. L. and Huang Q. 2006 Mapping of the methylation pattern of the hMSH2 promoter in colon cancer, using bisulfite genomic sequencing. J. Carcinog. 5, 22.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Karolina Przybylowska.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Langner, E., Przybylowska, K., Trzcinski, R. et al. Loss of hMSH2 gene expression correlates with improved survival in patients with sporadic colorectal cancer. J Genet 89, 101–104 (2010). https://doi.org/10.1007/s12041-010-0001-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12041-010-0001-6

Keywords

Navigation